Related Experiment Video
Updated: May 1, 2026

Field-Deployable Candidatus Liberibacter asiaticus Detection Using Recombinase Polymerase Amplification Combined with CRISPR-Cas12a
Published on: December 23, 2022
Hybridization chain reaction and CRISPR/Cas12a-integrated biosensor for precise Ago2 detection
Qiang Tang1, Jiayi Zhang2, Jialuo Pang1
1Guangxi Key Laboratory for Preclinical and Translational Research on Bone and Joint Degenerative Diseases, Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, Guangxi, 533000, China.
This study presents a novel electrochemiluminescence biosensor for detecting Argonaute 2 (Ago2) activity. The innovative system achieves ultra-sensitive detection of this key RNA interference enzyme, crucial for disease diagnostics.
Area of Science:
- Biomedical Engineering
- Molecular Biology
- Biotechnology
Background:
- Argonaute 2 (Ago2) is a critical enzyme in RNA interference (RNAi) pathway, vital for gene regulation.
- Dysregulation of Ago2 is implicated in various diseases, including cancer and viral infections, necessitating sensitive detection methods.
- Existing methods for Ago2 detection may lack the required sensitivity or specificity for comprehensive analysis.
Purpose of the Study:
- To develop and validate a highly sensitive and specific electrochemiluminescence (ECL) biosensor for Argonaute 2 (Ago2) activity.
- To leverage a multi-stage signal amplification strategy combining hybridization chain reaction (HCR) and CRISPR/Cas12a systems.
- To establish a robust platform for accurate biomarker detection applicable to clinical diagnostics and disease monitoring.
Main Methods:
- Designed a biosensor integrating hybridization chain reaction (HCR) for signal amplification.
- Incorporated the CRISPR/Cas12a system to further enhance signal through collateral cleavage activity.
- Utilized electrochemiluminescence (ECL) detection with a ruthenium-based luminophore for sensitive readout.
- Ago2-mediated cleavage of hairpin RNA initiated the HCR amplification cascade.
Main Results:
- Achieved an exceptional limit of detection (LOD) of 0.126 aM for Ago2 activity.
- Demonstrated high specificity, distinguishing Ago2 from other Argonaute proteins.
- Confirmed excellent reproducibility and stability, with 94% signal retention after two weeks.
- Validated real-world applicability by accurately detecting Ago2 in spiked cell lysates with high recovery rates.
Conclusions:
- The developed HCR-CRISPR/Cas12a-ECL biosensor offers a powerful platform for sensitive Ago2 detection.
- This innovative biosensor represents a significant advancement for next-generation diagnostic tools.
- The platform shows great potential for clinical diagnostics, disease monitoring, and therapeutic evaluation due to its sensitivity and adaptability.
More Related Videos
07:59Rapid and Specific Detection of Acinetobacter baumannii Infections Using a Recombinase Polymerase Amplification/Cas12a-based System
Published on: April 25, 2025
07:46On-site DNA Detection of Trypanosomatid Parasites and Nosema ceranae Through Alkaline Lysis Coupled to RPA/CRISPR/Cas12a System
Published on: July 18, 2025
Related Concept Videos
CRISPR
Homologous Recombination
CRISPR/Cas9 Genome Editing